Sepsis Following Chorioamnionitis: Causative Pathogens and Management

Microbiology of Post-Chorioamnionitis Sepsis

Group B Streptococcus (GBS) is the most common cause of early-onset neonatal sepsis following chorioamnionitis, particularly in term infants, according to the Centers for Disease Control and Prevention (CDC) 1, 3
Escherichia coli is the second most common pathogen, especially prevalent in preterm infants and cases with maternal chorioamnionitis, as reported by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) 2
Other gram-negative bacteria, including Klebsiella species and Pseudomonas species, are also significant causative organisms, as noted by the American Academy of Pediatrics (AAP) 4

For infants with suspected sepsis following maternal chorioamnionitis, ampicillin plus gentamicin is the recommended first-line antibiotic regimen, according to the ESCMID and the AAP 2, 5
This combination provides coverage against both GBS (ampicillin) and gram-negative organisms, including E. coli (gentamicin), as recommended by the AAP 5
In cases where gram-negative sepsis is strongly suspected, cefotaxime may be added to the regimen, as suggested by the ESCMID and the CDC 2, 3

All infants born to mothers with chorioamnionitis should undergo a limited evaluation, including blood culture and complete blood count with differential and platelets, as recommended by the CDC 1, 3
Full diagnostic evaluation, including lumbar puncture, should be performed if the infant shows signs of sepsis, according to the CDC and the AAP 1, 3

Early-onset sepsis (within the first 72 hours) following chorioamnionitis is most commonly caused by GBS and E. coli, as reported by the ESCMID 2
Late-onset sepsis (>72 hours to 1 month) more frequently involves coagulase-negative staphylococci, particularly in developed countries, according to the ESCMID 2

Adequate intrapartum antibiotic prophylaxis (≥4 hours of penicillin, ampicillin, or cefazolin before delivery) significantly reduces the risk of GBS sepsis in the newborn, as recommended by the CDC and the AAP 1, 6

Relying solely on maternal GBS screening results can miss cases of sepsis, as infants can develop GBS disease despite negative maternal screening, as noted by the AAP 6
Delaying antibiotic treatment while awaiting culture results can lead to poor outcomes; treatment should begin immediately after cultures are obtained, according to the AAP and the ESCMID 5